Pandorum Technologies Secures 18 Million in Series B Funding to Expand Regenerative Medicine Portfolio
Pandorum Technologies, a biotechnology firm specialising in programmable regenerative medicine, has raised USD 18 million in a Series B funding…
Ashish Kacholia
Read More